Report Detail

Pharma & Healthcare Global (United States, European Union and China) Thyroid Cancer Treatment Market Research Report 2019-2025

  • RnM3622632
  • |
  • 29 July, 2019
  • |
  • Global
  • |
  • 111 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global (United States, European Union and China) Thyroid Cancer Treatment Market Research Report 2019-2025

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Thyroid Cancer Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Surgery
      • 1.3.3 Iodine Therapy
      • 1.3.4 External Radiotherapy
      • 1.3.5 Thyroxin Treatment
      • 1.3.6 Chemotherapy
      • 1.3.7 Drugs
    • 1.4 Market Segment by Application
      • 1.4.1 Global Thyroid Cancer Treatment Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Oncology centers
      • 1.4.4 Hospital Pharmacies
      • 1.4.5 Retail Pharmacies
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Thyroid Cancer Treatment Market Size
      • 2.1.1 Global Thyroid Cancer Treatment Revenue 2014-2025
      • 2.1.2 Global Thyroid Cancer Treatment Sales 2014-2025
    • 2.2 Thyroid Cancer Treatment Growth Rate by Regions
      • 2.2.1 Global Thyroid Cancer Treatment Sales by Regions 2014-2019
      • 2.2.2 Global Thyroid Cancer Treatment Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Thyroid Cancer Treatment Sales by Manufacturers
      • 3.1.1 Thyroid Cancer Treatment Sales by Manufacturers 2014-2019
      • 3.1.2 Thyroid Cancer Treatment Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Thyroid Cancer Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Thyroid Cancer Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Thyroid Cancer Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Thyroid Cancer Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Thyroid Cancer Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Thyroid Cancer Treatment Market
    • 3.6 Key Manufacturers Thyroid Cancer Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Surgery Sales and Revenue (2014-2019)
      • 4.1.2 Iodine Therapy Sales and Revenue (2014-2019)
      • 4.1.3 External Radiotherapy Sales and Revenue (2014-2019)
      • 4.1.4 Thyroxin Treatment Sales and Revenue (2014-2019)
      • 4.1.5 Chemotherapy Sales and Revenue (2014-2019)
      • 4.1.6 Drugs Sales and Revenue (2014-2019)
    • 4.2 Global Thyroid Cancer Treatment Sales Market Share by Type
    • 4.3 Global Thyroid Cancer Treatment Revenue Market Share by Type
    • 4.4 Thyroid Cancer Treatment Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Thyroid Cancer Treatment Sales by Application

    6 United States

    • 6.1 United States Thyroid Cancer Treatment Breakdown Data by Company
    • 6.2 United States Thyroid Cancer Treatment Breakdown Data by Type
    • 6.3 United States Thyroid Cancer Treatment Breakdown Data by Application

    7 European Union

    • 7.1 European Union Thyroid Cancer Treatment Breakdown Data by Company
    • 7.2 European Union Thyroid Cancer Treatment Breakdown Data by Type
    • 7.3 European Union Thyroid Cancer Treatment Breakdown Data by Application

    8 China

    • 8.1 China Thyroid Cancer Treatment Breakdown Data by Company
    • 8.2 China Thyroid Cancer Treatment Breakdown Data by Type
    • 8.3 China Thyroid Cancer Treatment Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Thyroid Cancer Treatment Breakdown Data by Company
    • 9.2 Rest of World Thyroid Cancer Treatment Breakdown Data by Type
    • 9.3 Rest of World Thyroid Cancer Treatment Breakdown Data by Application
    • 9.4 Rest of World Thyroid Cancer Treatment Breakdown Data by Countries
      • 9.4.1 Rest of World Thyroid Cancer Treatment Sales by Countries
      • 9.4.2 Rest of World Thyroid Cancer Treatment Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Baxter
      • 10.1.1 Baxter Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Thyroid Cancer Treatment
      • 10.1.4 Thyroid Cancer Treatment Product Introduction
      • 10.1.5 Baxter Recent Development
    • 10.2 Mylan
      • 10.2.1 Mylan Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Thyroid Cancer Treatment
      • 10.2.4 Thyroid Cancer Treatment Product Introduction
      • 10.2.5 Mylan Recent Development
    • 10.3 Alara
      • 10.3.1 Alara Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Thyroid Cancer Treatment
      • 10.3.4 Thyroid Cancer Treatment Product Introduction
      • 10.3.5 Alara Recent Development
    • 10.4 Bristol Myers
      • 10.4.1 Bristol Myers Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Thyroid Cancer Treatment
      • 10.4.4 Thyroid Cancer Treatment Product Introduction
      • 10.4.5 Bristol Myers Recent Development
    • 10.5 Abbott
      • 10.5.1 Abbott Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Thyroid Cancer Treatment
      • 10.5.4 Thyroid Cancer Treatment Product Introduction
      • 10.5.5 Abbott Recent Development
    • 10.6 Teva
      • 10.6.1 Teva Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Thyroid Cancer Treatment
      • 10.6.4 Thyroid Cancer Treatment Product Introduction
      • 10.6.5 Teva Recent Development
    • 10.7 App pharmaceuticals
      • 10.7.1 App pharmaceuticals Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Thyroid Cancer Treatment
      • 10.7.4 Thyroid Cancer Treatment Product Introduction
      • 10.7.5 App pharmaceuticals Recent Development
    • 10.8 Jerome Stevens
      • 10.8.1 Jerome Stevens Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Thyroid Cancer Treatment
      • 10.8.4 Thyroid Cancer Treatment Product Introduction
      • 10.8.5 Jerome Stevens Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Thyroid Cancer Treatment Sales Channels
      • 11.2.2 Thyroid Cancer Treatment Distributors
    • 11.3 Thyroid Cancer Treatment Customers

    12 Market Forecast

    • 12.1 Global Thyroid Cancer Treatment Sales and Revenue Forecast 2019-2025
    • 12.2 Global Thyroid Cancer Treatment Sales Forecast by Type
    • 12.3 Global Thyroid Cancer Treatment Sales Forecast by Application
    • 12.4 Thyroid Cancer Treatment Forecast by Regions
      • 12.4.1 Global Thyroid Cancer Treatment Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Thyroid Cancer Treatment Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Thyroid cancer is cancer that develops from the tissues of the thyroid gland. It is a disease in which cells grow abnormally and have the potential to spread to other parts of the body. Symptoms can include swelling or a lump in the neck.
      In 2019, the market size of Thyroid Cancer Treatment is 340 million US$ and it will reach 2090 million US$ in 2025, growing at a CAGR of 25.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Thyroid Cancer Treatment.

      This report studies the global market size of Thyroid Cancer Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Thyroid Cancer Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Baxter
      Mylan
      Alara
      Bristol Myers
      Abbott
      Teva
      App pharmaceuticals
      Jerome Stevens

      Market Segment by Product Type
      Surgery
      Iodine Therapy
      External Radiotherapy
      Thyroxin Treatment
      Chemotherapy
      Drugs

      Market Segment by Application
      Hospitals
      Oncology centers
      Hospital Pharmacies
      Retail Pharmacies

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Thyroid Cancer Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Thyroid Cancer Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Thyroid Cancer Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025


      Summary:
      Get latest Market Research Reports on Thyroid Cancer Treatment. Industry analysis & Market Report on Thyroid Cancer Treatment is a syndicated market report, published as Global (United States, European Union and China) Thyroid Cancer Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Thyroid Cancer Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,626.23
      3,939.35
      5,252.47
      2,967.41
      4,451.11
      5,934.81
      354,318.72
      531,478.08
      708,637.44
      233,780.36
      350,670.54
      467,560.72
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report